Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums
There are several types of depression medications (antidepressants) used to treat depression and conditions that have depression as a component of the disease, such as bipolar disorder. These drugs improve symptoms of depression by increasing the availability of certain brain chemicals called neurotransmitters. It is believed that these brain chemicals can help regulate brain circuits that affect emotions.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.
Depressive disorders are appearing earlier in life with the average age of onset 50 years ago being 29 whereas recent statistics indicate it at just 14.5yrs in today's society. Women between the ages of 25-44 are most often affected by depression with a major cause of depression in women being the inability to express or handle Anger. More than a third of the Europe population suffers from some sort of a mental disorder each year.A major National Institute of Mental Health study showed that fewer than 50 percent of people become symptom-free on antidepressants. Antidepressants can take several weeks to take effect. Only three people out of five will see their depression improve the first time they start taking an antidepressant. The treatment of depression is important because people with untreated depression have a lower quality of life, a higher risk of suicide, and worse physical outcomes if they have any medical conditions besides depression. Antidepressants are drugs prescribed by doctors to treat depression and sometimes anxiety.
List of Best International Conferences
List of Related Societies & Associations
List of Related Companies
The London School of Economics estimated the total loss of output due to depression and chronic anxiety in the UK at some 12 billion pounds a year. Approximately 18.8 million American adults, or about 9.5 percent of the U.S. population age 18 and older in a given year, have a depressive disorder.
Depression is a medical illness that involves the brain and is characterized by sadness, loss of interest, feelings of guilt, low self-worth, disturbed sleep, poor concentration and feelings of tiredness. Factors that cause depression are genes (DNA), brain chemistry and environmental factors like stress. Other symptoms of depression include changes in sleeping habits such as sleeping poorly or sleeping more than usual, strong feelings of despair, feeling of hopelessness. Depression usually starts at a young age and it has been observed that it affects women more often than men and also unemployed people are at high risk. When mild, it can be treated without medicines but when it is moderate or severe people may need medication for its treatment. Medicines used to treat depression are generally referred to as antidepressants. There are three major types of depression medicines; Sustained release medicine, controlled release medicine, extended release medicine. Wellbutrin SR® is a sustained-release medicine. Paxil CR® is a controlled-release medicine. Effexor XR®, Wellbutrin XL®, and Prozac Weekly® are extended release medicines. Antidepressants help to overcome the problems related to depression like anxiety, pain, and insomnia. Studies have shown that Paroxetine (Paxil®) and duloxetine (Cymbalta®) helped people with depression and chronic pain. Even insomnia could be treated through Fluoxetine (Prozac®), mirtazapine (Remeron®), paroxetine (Paxil®), and sertraline (Zoloft®)
Recent studies have shown that people with anxiety disorders develop Depression. Hence to improve patient care scientists and researchers are integrating innovations and advanced techniques to prevent and treat depression and disease associated with it. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about Depression Medicines. Around 20 National symposiums and Workshops are going to be held across the globe which includes “International Forum on Mood and Anxiety Disorders”, “Clinical Trials in CNS 2014”, “Patient First 2014” , “Family Medicine: Women`s Health 2014” and many more.
OMICS International has been one the explorers in organizing scientific events where scientists, students and business professionals reconcile and discuss the latest and advanced inventions and discoveries. OMICS Group International is a pioneer and leading science event organizer, which publishes around 400 open access journals and conducts over 300 Medical, Clinical, Engineering, Life Sciences, Phrama International Conferences across the globe to accelerate the knowledge transfer through debates, round table discussions, poster presentations, workshops, symposia and exhibitions. Omics group has support from more than 1000 scientific associations and 30,000 editorial board members and 3.5 million readers.
Relevant Conferences
1. Annual International Conference on Internal Medicine 2015, May 4-7, 2015 Athens, Greece
2. 61st AANEM 2014 Annual Meeting - American Association of Neuromuscular & Electro diagnostic Medicine Oct 29 - Nov 1, 2014, Savannah, GA, United States
3. The 2015 Ageing Summit February 10-12, 2015 London, United Kingdom
4. Clinical Trials in CNS 2014, November 11-14, 2014, London United kingdom
5. 13th Annual Psychopharmacology Update: Pharmacotherapies for Treatment-Resistant Patients 2014 October 25, 2014 Cincinnati, OH, United States
6. Patient First 2014 November 26-27, 2014 London, United Kingdom
7. Coronary Artery Disease: Prevention, Detection, and Treatment 2014 November 21-23, 2014 Las Vegas, NV, United States
8. Family Medicine: Women`s Health 2014 November 6-15, 2014 Fort Lauderdale, FL, United States
9. First Middle East North Africa Committee for Research and Treatment in Multiple Sclerosis (MENACTRIMS) Congress 2014 October 17-18, 2014 Dubai, United Arab Emirates
10. 23rd European Congress of Psychiatry 2015 March 28-31, 2015 Vienna, Austria
This page will be updated regularly.
This page was last updated on November 5, 2024
